Therapie der koronaren Dreigefäßerkrankung bei Patienten über 75 Jahren

Abstract

Older patients benefit from an interventional or surgical revascularization in the context of ACS. In contrast, in elderly with stable CAD optimal medical therapy provides a reasonable alternative to invasive therapy without increase in mortality.